Trial Profile
A study evaluating efficacy of mirabegron against treatment naive female patients with overactive bladder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 29 Nov 2017 New trial record